Your browser doesn't support javascript.
loading
Brain Dp140 alters glutamatergic transmission and social behaviour in the mdx52 mouse model of Duchenne muscular dystrophy.
Hashimoto, Yasumasa; Kuniishi, Hiroshi; Sakai, Kazuhisa; Fukushima, Yuta; Du, Xuan; Yamashiro, Kunihiko; Hori, Kei; Imamura, Michihiro; Hoshino, Mikio; Yamada, Mitsuhiko; Araki, Toshiyuki; Sakagami, Hiroyuki; Takeda, Shin'ichi; Itaka, Keiji; Ichinohe, Noritaka; Muntoni, Francesco; Sekiguchi, Masayuki; Aoki, Yoshitsugu.
Afiliación
  • Hashimoto Y; Department of Molecular Therapy, National Institute of Neuroscience, National Center of Neurology and Psychiatry (NCNP), Kodaira, Tokyo 187-8502, Japan; Department of NCNP Brain Physiology and Pathology, Graduate school of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU), Bunk
  • Kuniishi H; Department of Degenerative Neurological Diseases, National Institute of Neuroscience, NCNP, Kodaira, Tokyo 187-8502, Japan; Department of Neuropsychopharmacology, National Institute of Mental Health, NCNP, Kodaira, Tokyo 187-8502, Japan.
  • Sakai K; Department of Ultrastructural Research, National Institute of Neuroscience, NCNP, Kodaira, Tokyo 187-8502, Japan.
  • Fukushima Y; Department of Biofunction Research, Institute of Biomaterials and Bioengineering, Tokyo Medical and Dental University (TMDU), Chiyoda, Tokyo 101-0062 Japan.
  • Du X; Department of Biofunction Research, Institute of Biomaterials and Bioengineering, Tokyo Medical and Dental University (TMDU), Chiyoda, Tokyo 101-0062 Japan.
  • Yamashiro K; Department of Biochemistry and Cellular Biology, National Institute of Neuroscience, NCNP, Kodaira, Tokyo 187-8502, Japan.
  • Hori K; Department of Biochemistry and Cellular Biology, National Institute of Neuroscience, NCNP, Kodaira, Tokyo 187-8502, Japan.
  • Imamura M; Department of Molecular Therapy, National Institute of Neuroscience, National Center of Neurology and Psychiatry (NCNP), Kodaira, Tokyo 187-8502, Japan.
  • Hoshino M; Department of NCNP Brain Physiology and Pathology, Graduate school of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU), Bunkyo, Tokyo 113-8510 Japan; Department of Biochemistry and Cellular Biology, National Institute of Neuroscience, NCNP, Kodaira, Tokyo 187-8502, Japan.
  • Yamada M; Department of Neuropsychopharmacology, National Institute of Mental Health, NCNP, Kodaira, Tokyo 187-8502, Japan.
  • Araki T; Department of Peripheral Nervous System Research, National Institute of Neuroscience, NCNP, Kodaira, Tokyo 187-8502, Japan.
  • Sakagami H; Department of Anatomy, Kitasato University School of Medicine, Sagamihara, Kanagawa 252-0374, Japan.
  • Takeda S; Department of Molecular Therapy, National Institute of Neuroscience, National Center of Neurology and Psychiatry (NCNP), Kodaira, Tokyo 187-8502, Japan.
  • Itaka K; Department of Biofunction Research, Institute of Biomaterials and Bioengineering, Tokyo Medical and Dental University (TMDU), Chiyoda, Tokyo 101-0062 Japan.
  • Ichinohe N; Department of Ultrastructural Research, National Institute of Neuroscience, NCNP, Kodaira, Tokyo 187-8502, Japan.
  • Muntoni F; Dubowitz Neuromuscular Centre, NIHR Great Ormond Street Hospital Biomedical Research Centre, Great Ormond Street Institute of Child Health, University College London, & Great Ormond Street Hospital Trust, 30 Guilford Street, London, UK.
  • Sekiguchi M; Department of Degenerative Neurological Diseases, National Institute of Neuroscience, NCNP, Kodaira, Tokyo 187-8502, Japan. Electronic address: sekiguch@ncnp.go.jp.
  • Aoki Y; Department of Molecular Therapy, National Institute of Neuroscience, National Center of Neurology and Psychiatry (NCNP), Kodaira, Tokyo 187-8502, Japan; Department of NCNP Brain Physiology and Pathology, Graduate school of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU), Bunk
Prog Neurobiol ; 216: 102288, 2022 09.
Article en En | MEDLINE | ID: mdl-35654209
ABSTRACT
Duchenne muscular dystrophy (DMD) is a muscle disorder caused by DMD mutations and is characterized by neurobehavioural comorbidities due to dystrophin deficiency in the brain. The lack of Dp140, a dystrophin short isoform, is clinically associated with intellectual disability and autism spectrum disorders (ASDs), but its postnatal functional role is not well understood. To investigate synaptic function in the presence or absence of brain Dp140, we utilized two DMD mouse models, mdx23 and mdx52 mice, in which Dp140 is preserved or lacking, respectively. ASD-like behaviours were observed in pups and 8-week-old mdx52 mice lacking Dp140. Paired-pulse ratio of excitatory postsynaptic currents, glutamatergic vesicle number in basolateral amygdala neurons, and glutamatergic transmission in medial prefrontal cortex-basolateral amygdala projections were significantly reduced in mdx52 mice compared to those in wild-type and mdx23 mice. ASD-like behaviour and electrophysiological findings in mdx52 mice were ameliorated by restoration of Dp140 following intra-cerebroventricular injection of antisense oligonucleotide drug-induced exon 53 skipping or intra-basolateral amygdala administration of Dp140 mRNA-based drug. Our results implicate Dp140 in ASD-like behaviour via altered glutamatergic transmission in the basolateral amygdala of mdx52 mice.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Distrofina / Distrofia Muscular de Duchenne Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: Prog Neurobiol Año: 2022 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Distrofina / Distrofia Muscular de Duchenne Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: Prog Neurobiol Año: 2022 Tipo del documento: Article
...